apomorphine has been researched along with roxindole in 6 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 4 (66.67) | 18.2507 |
| 2000's | 2 (33.33) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Barnickel, G; Böttcher, H; Eiermann, V; Haase, AF; Hausberg, HH; Seyfried, CA | 1 |
| Carrupt, PA; Crivori, P; Cruciani, G; Testa, B | 1 |
| Audinot, V; Boutin, JA; Cussac, D; Maiofiss, L; Millan, MJ; Newman-Tancredi, A | 1 |
| Bartoszyk, GD; Seyfried, CA | 1 |
| Bartoszyk, GD; Harting, J; Minck, KO | 1 |
| Kolodziejczyk, K; Maj, J; Rogóz, Z; Skuza, G | 1 |
6 other study(ies) available for apomorphine and roxindole
| Article | Year |
|---|---|
Synthesis and dopaminergic activity of some 3-(1,2,3,6-tetrahydro-1-pyridylalkyl)indoles. A novel conformational model to explain structure-activity relationships.
Topics: Animals; Binding, Competitive; Corpus Striatum; Dopamine Agents; In Vitro Techniques; Indoles; Male; Models, Molecular; Molecular Conformation; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior; Structure-Activity Relationship | 1992 |
Predicting blood-brain barrier permeation from three-dimensional molecular structure.
Topics: Blood-Brain Barrier; Databases, Factual; Models, Chemical; Molecular Conformation; Multivariate Analysis; Permeability; Pharmaceutical Preparations; Pharmacokinetics; Structure-Activity Relationship | 2000 |
Differential actions of antiparkinson agents at multiple classes of monoaminergic receptor. I. A multivariate analysis of the binding profiles of 14 drugs at 21 native and cloned human receptor subtypes.
Topics: Animals; Antiparkinson Agents; Binding Sites; Binding, Competitive; Cholinergic Antagonists; Cloning, Molecular; Cluster Analysis; Dopamine Agonists; Humans; Rats; Receptor, Muscarinic M1; Receptors, Adrenergic, alpha-1; Receptors, Adrenergic, alpha-2; Receptors, Adrenergic, beta; Receptors, Dopamine D1; Receptors, Dopamine D2; Receptors, Dopamine D3; Receptors, Histamine H1; Receptors, Muscarinic; Receptors, Neurotransmitter; Receptors, Serotonin | 2002 |
Sensitivity of dopamine D2 receptors following long-term treatment with roxindole.
Topics: 4-Butyrolactone; Animals; Apomorphine; Corpus Striatum; Dihydroxyphenylalanine; Dopamine Agents; Down-Regulation; Drug Interactions; Haloperidol; Indoles; Injections, Intraperitoneal; Male; Oxindoles; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior | 1994 |
Roxindole: psychopharmacological profile of a dopamine D2 autoreceptor agonist.
Topics: 2,3,4,5-Tetrahydro-7,8-dihydroxy-1-phenyl-1H-3-benzazepine; Animals; Apomorphine; Avoidance Learning; Azepines; Catalepsy; Dopamine Agonists; Dose-Response Relationship, Drug; Drug Evaluation, Preclinical; Drug Interactions; Indoles; Male; Mice; Motor Activity; Oxindoles; Pyridines; Rats; Rats, Wistar; Receptors, Dopamine D2; Stereotyped Behavior | 1996 |
Roxindole, a potential antidepressant. I. Effect on the dopamine system.
Topics: Amphetamine; Analysis of Variance; Animals; Antidepressive Agents; Apomorphine; Dopamine Agonists; Drug Administration Schedule; Indoles; Male; Mice; Mice, Inbred Strains; Motor Activity; Oxindoles; Pyridines; Rats; Rats, Wistar; Stereotyped Behavior | 1996 |